Pouxvielh K, Marotel M, Drouillard A, Villard M, Moreews M, Bossan A
Sci Adv. 2024; 10(35):eadn0164.
PMID: 39196934
PMC: 11352832.
DOI: 10.1126/sciadv.adn0164.
Chen S, Liu J, Huang S
Front Pharmacol. 2024; 15:1370663.
PMID: 38953110
PMC: 11215192.
DOI: 10.3389/fphar.2024.1370663.
Long Y, Lu K, Xia C, Feng J, Li W, Ma Y
Clin Exp Immunol. 2024; 216(2):132-145.
PMID: 38386917
PMC: 11036109.
DOI: 10.1093/cei/uxae016.
Jiang B, Zhou H, Xie X, Xia T, Ke C
Heliyon. 2024; 10(4):e25721.
PMID: 38375265
PMC: 10875430.
DOI: 10.1016/j.heliyon.2024.e25721.
Bourinet M, Anty R, Gual P, Luci C
JHEP Rep. 2024; 6(2):100962.
PMID: 38304237
PMC: 10831956.
DOI: 10.1016/j.jhepr.2023.100962.
IL-21R-STAT3 signalling initiates a differentiation program in uterine tissue-resident NK cells to support pregnancy.
Han M, Hu L, Wu D, Zhang Y, Li P, Zhao X
Nat Commun. 2023; 14(1):7109.
PMID: 37925507
PMC: 10625623.
DOI: 10.1038/s41467-023-42990-0.
Functional crosstalk and regulation of natural killer cells in tumor microenvironment: Significance and potential therapeutic strategies.
Wang L, Chen Z, Liu G, Pan Y
Genes Dis. 2023; 10(3):990-1004.
PMID: 37396514
PMC: 10308134.
DOI: 10.1016/j.gendis.2022.07.009.
The role of Raptor in lymphocytes differentiation and function.
Tang J, Yang L, Guan F, Miller H, Camara N, James L
Front Immunol. 2023; 14:1146628.
PMID: 37283744
PMC: 10239924.
DOI: 10.3389/fimmu.2023.1146628.
Myc controls NK cell development, IL-15-driven expansion, and translational machinery.
Khameneh H, Fonta N, Zenobi A, Niogret C, Ventura P, Guerra C
Life Sci Alliance. 2023; 6(7).
PMID: 37105715
PMC: 10140547.
DOI: 10.26508/lsa.202302069.
Inflammatory-driven NK cell maturation and its impact on pathology.
Bourayou E, Golub R
Front Immunol. 2022; 13:1061959.
PMID: 36569860
PMC: 9780665.
DOI: 10.3389/fimmu.2022.1061959.
Severe COVID-19 patients display hyper-activated NK cells and NK cell-platelet aggregates.
Malengier-Devlies B, Filtjens J, Ahmadzadeh K, Boeckx B, Vandenhaute J, De Visscher A
Front Immunol. 2022; 13:861251.
PMID: 36275702
PMC: 9581751.
DOI: 10.3389/fimmu.2022.861251.
NK cells contribute to reovirus-induced IFN responses and loss of tolerance to dietary antigen.
Brigleb P, Kouame E, Fiske K, Taylor G, Urbanek K, Sanchez L
JCI Insight. 2022; 7(16).
PMID: 35993365
PMC: 9462493.
DOI: 10.1172/jci.insight.159823.
The 'Danse Macabre'-Neutrophils the Interactive Partner Affecting Oral Cancer Outcomes.
Hadjigol S, Shah B, OBrien-Simpson N
Front Immunol. 2022; 13:894021.
PMID: 35784290
PMC: 9243430.
DOI: 10.3389/fimmu.2022.894021.
IL27 Signaling Serves as an Immunologic Checkpoint for Innate Cytotoxic Cells to Promote Hepatocellular Carcinoma.
Aghayev T, Mazitova A, Fang J, Peshkova I, Rausch M, Hung M
Cancer Discov. 2022; 12(8):1960-1983.
PMID: 35723626
PMC: 9357073.
DOI: 10.1158/2159-8290.CD-20-1628.
Majie Cataplasm Promotes Th1 Response to Fight against Asthmatic Th2 Inflammation through NKs.
Ji W, Shi H, Feng T, Zhang S, Liu H, Xu W
Evid Based Complement Alternat Med. 2022; 2022:6745420.
PMID: 35600943
PMC: 9119792.
DOI: 10.1155/2022/6745420.
Combined spinal and general anesthesia attenuate tumor promoting effects of surgery. An experimental animal study.
Inoue G, Pimenta R, Camargo J, Viana N, Guimaraes V, Srougi M
Ann Med Surg (Lond). 2022; 75:103398.
PMID: 35386811
PMC: 8977895.
DOI: 10.1016/j.amsu.2022.103398.
Extracellular matrix proteins regulate NK cell function in peripheral tissues.
Bunting M, Vyas M, Requesens M, Langenbucher A, Schiferle E, Manguso R
Sci Adv. 2022; 8(11):eabk3327.
PMID: 35294229
PMC: 8926340.
DOI: 10.1126/sciadv.abk3327.
Mesenchymal stem cells and natural killer cells interaction mechanisms and potential clinical applications.
Abbasi B, Shamsasenjan K, Ahmadi M, Beheshti S, Saleh M
Stem Cell Res Ther. 2022; 13(1):97.
PMID: 35255980
PMC: 8900412.
DOI: 10.1186/s13287-022-02777-4.
Challenges and Recent Advances in NK Cell-Targeted Immunotherapies in Solid Tumors.
Lian G, Mak T, Yu X, Lan H
Int J Mol Sci. 2022; 23(1).
PMID: 35008589
PMC: 8745474.
DOI: 10.3390/ijms23010164.
Chronic IL-15 Stimulation and Impaired mTOR Signaling and Metabolism in Natural Killer Cells During Acute Myeloid Leukemia.
Bou-Tayeh B, Laletin V, Salem N, Just-Landi S, Fares J, Leblanc R
Front Immunol. 2022; 12:730970.
PMID: 34975835
PMC: 8718679.
DOI: 10.3389/fimmu.2021.730970.